site stats

P-selectin antibody patent

WebCD62P is a 140 kD type I transmembrane glycoprotein also known as P-selectin, platelet activation-dependent granule membrane protein (PADGEM), and GMP-140. It is expressed …

US Patent for Anti-P-selectin antibodies Patent (Patent

WebNov 29, 2024 · The Platelet Factor-4 (PF4)-Dependent p-Selectin Expression Assay (PEA) Is Highly Accurate for the Detection of Pathogenic HIT Antibodies: Results of a 440-Sample Prospective Blinded Study Blood American Society of Hematology 331. Pathophysiology of Thrombosis: Risk Factors and Thromboembolism November 29, 2024 WebMar 24, 2024 · Lack of P-selectin in mice induces the development of a lupus-like syndrome and patients with cutaneous lupus have reduced P-selectin expression in skin vessels. ... of PSGL-1 and low levels of PSGL-1 in neutrophils from SLE patients associated with the presence of anti-dsDNA antibodies, clinical lung involvement, Raynaud's phenomenon, … everything i need https://fredstinson.com

Senior Vice President, Head of Platform - LinkedIn

WebOct 15, 2024 · The glycoprotein (GP) P-selectin, a member of the C-type lectin family, 1 is rapidly translocated from α-granules of platelets and Weibel-Palade bodies of endothelial cells to the cell surface on stimulation. 2 3 It mediates rolling of platelets and neutrophils on activated endothelial cells 4 5 as well as interactions of activated platelets with … WebThe P-selectin antibodies can be used to treat inflammatory and thrombotic conditions, e.g., sickle cell disease, pain crisis associated with sickle cell disease, deep vein thrombosis, asthma,... WebCD62P is a 140 kD type I transmembrane glycoprotein also known as P-selectin, platelet activation-dependent granule membrane protein (PADGEM), and GMP-140. It is expressed … everything i needed i learned in kindergarten

Platelet Factor-4 (PF4)-Dependent p-Selectin Expression Assay …

Category:Characterization of Two Anti-P-Selectin Monoclonal Antibodies …

Tags:P-selectin antibody patent

P-selectin antibody patent

APC anti-human CD62P P-Selectin Antibody anti-CD62P

WebMar 23, 2024 · 1. Delivered a preclinical candidate for inflammation (US Patent 2014039308 - issued) This work was published in Nature (doi: … WebNational Center for Biotechnology Information

P-selectin antibody patent

Did you know?

WebP-Selectin Antibody (CTB201) is an IgG 1 κ mouse monoclonal P-Selectin antibody (also designated CD62 antibody, SELP antibody, selectin P antibody) suitable for the detection of the P-Selectin protein of mouse, rat and human origin by WB, IP, IF, IHC(P) and FCM. P-Selectin Antibody (CTB201) is available as both the non-conjugated anti-P-Selectin … WebAntibodies are disclosed which bind specifically to P-selectin and which block the binding of PSGL-1 to P-selectin. These anti-P-selectin antibodies may also cause dissociation of …

WebP-Selectin (CD62P), previously termed PADGEM or GMP-140, is a single chain glycoprotein of 140 kDa expressed in platelets and endothelial cells. In platelets, P-selectin is stored in … WebP-selectin assays and methods of use thereof - Patent WO-9821591-A1 - PubChem WO-9821591-A1 chemical patent summary. This application requires Javascript. Please turn on Javascript in order to use this application.

WebNov 29, 2024 · The Platelet Factor-4 (PF4)-Dependent p-Selectin Expression Assay (PEA) Is Highly Accurate for the Detection of Pathogenic HIT Antibodies: Results of a 440-Sample … WebWestern Blot analysis of P-Selectin (CD62P) in various cell lines using a P-Selectin (CD62P) Polyclonal antibody ( Product # PA5-120169) at a dilution of 1:1,000. 25 µg of lysate or protein were loaded into each lane. A blocking buffer of 3% nonfat dry milk in TBST was used. An HRP conjugated Goat Anti-Rabbit IgG (H+L) secondary antibody was ...

WebThe invention relates to the use of an anti-P-selectin antibody or binding fragment thereof, suitably crizanlizumab or a binding fragment thereof in the treatment of myelofibrosis (MF). The invention also relates to a pharmaceutical combination comprising a) an anti-P-Selectin antibody and b) at least one further therapeutic agent, preferably ruxolitinib or a …

WebThis invention relates to anti-P-selectin antibodies and, in particular, to anti-P-selectin antibodies and variants thereof that contain an Fc part derived from human origin and do … everything i need film version 下载WebCompounds, compositions, and methods for treating and/or preventing at least one disease, disorder, and/or condition N associated with E-selectin, galectin-3, and/or CXCR4 chemoki everything i need for a newborn babyWebJan 18, 2002 · Compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface of T cells or natural killer (NK) cells can be used to induce T cell or NK cell depletion and/or to induce T cell or NK cell apoptosis. The compounds and methods of the invention can be used to control unwanted T cell- or NK cell-mediated immune responses in conditions … everything i need for life and godlinessWebThe RB40.34 monoclonal antibody specifically binds to mouse P-selectin (CD62P), a 140 kDa protein which is expressed ... P-selectin, but not P-selectin glycoprotein ligand 1. Blood. 2002; 99(3):946-956. ... BD Biosciences will not be held responsible for a patent infringement or other violations that may occur with the use of our products ... everything i need for warlock robesWebCD62P/P-Selectin is a type-I transmembrane glycoprotein that is largely expressed and stored in intracellular granules by resting platelets, megakaryocytes, and vascular endothelial cells (1,2). The restricted expression pattern of CD62P/P-Selectin positions this molecule as a key regulator of hemostasis, thrombosis, and inflammation. everything i need for a newbornWebFeb 6, 2024 · While IL-1β antibody can reduce neutrophil infiltration and matrix metalloproteinase-2 activity [11], IL-1α antibody blunts the activation of endothelial cells and the expression of adhesion molecules in the BBB thereby reducing penumbral macrophage content and neurotoxic mediators, such as MMPs [12]. everything i need for a pcWebNov 5, 2024 · Crizanlizumab, a first-in-class humanized anti-P-selectin IgG2 mAb, is approved in >40 countries to reduce/prevent VOCs in SCD patients aged ≥16 yrs. Inclacumab, a fully human anti-P-selectin IgG4 mAb, is in clinical development for SCD. brownson church southern pines